Investigators presented 12-month phase 2 data on subretinal OCU410 gene therapy in patients with geographic atrophy.
European Affiliate, based in Amsterdam, to support upcoming marketing authorization submissions, OCU410 Phase 3 development program, and ...
Une quarantaine d'agents se sont rassemblés ce lundi 5 octobre devant le Centre d'exploitation de Cintegabelle, en ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results